Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Volume 32, Issue 5
  5. Article
Volume 32, Issue 5
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background and Objective

The literature suggests that statins may increase superoxide dismutase (SOD) levels by different mechanisms. These effects may contribute to the antioxidant and anti-inflammatory effects of statins, which are thought to be beneficial in preventing cardiovascular events. However, there are also conflicting results concerning the effect of statins on SOD levels. The goal of this systematic review was to evaluate the effect of statin therapy on SOD activity.

Methods

This systematic review was performed based on the PRISMA statement. The terms (“statin” or “HMG-CoA reductase inhibitor” OR “lipid-lowering agents” OR “Atorvastatin” OR “Simvastatin” OR “Pravastatin” OR “Fluvastatin” OR “Lovastatin”) AND (“superoxide dismutase” OR “SOD” OR “anti-oxidative” OR “oxidative stress”) were searched in database systems Google Scholar, PubMed/MEDLINE, and Scopus from inception to April 2022.

Results

A total of 14 controlled clinical trials - 10 randomized and 4 non-randomized - were found to be eligible. Four studies measured SOD levels in plasma, six in serum, two in red blood cells, one in venous blood, and one on both red blood cells and venous blood matrices. Seven clinical trials used atorvastatin, six used simvastatin, and four used rosuvastatin. Six studies reported an increase in SOD activity, seven found no significant changes, and one showed a reduced SOD activity.

Conclusion

Our systematic review suggests that treatment with statins has a positive effect on SOD activity. However, evidence from further randomized controlled trials is required to confirm the potential antioxidant effect of statin therapy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867331666230831145809
2023-09-11
2025-05-10

  • From This Site

    /content/journals/cmc/10.2174/0929867331666230831145809
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Blais, J.E.; Wei, Y.; Yap, K.K.W.; Alwafi, H.; Ma, T.T.; Brauer, R.; Lau, W.C.Y.; Man, K.K.C.; Siu, C.W.; Tan, K.C.B.; Wong, I.C.K.; Wei, L.; Chan, E.W. Trends in lipid-modifying agent use in 83 countries.Atherosclerosis2021328445110.1016/j.atherosclerosis.2021.05.016
     [Google Scholar]
  2. BonettiP. LermanL.O. NapoliC. LermanA. Statin effects beyond lipid lowering—are they clinically relevant?Eur. Heart J.200324322524810.1016/S0195‑668X(02)00419‑012590901
     [Google Scholar]
  3. OesterleA. LaufsU. LiaoJ.K. Pleiotropic effects of statins on the cardiovascular system.Circ. Res.2017120122924310.1161/CIRCRESAHA.116.30853728057795
     [Google Scholar]
  4. Chamani S.; Liberale L.; Mobasheri L.; Montecucco F.; Al-Rasadi K.; Jamialahmadi T.; Sahebkar A.; The role of statins in the differentiation and function of bone cells. Eur. J. Clin. Invest., 2021, 51(7), e13534.10.1111/eci.1353433656763
  5. BahramiA. BoS. JamialahmadiT. SahebkarA. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms.Ageing Res. Rev.20205810102410.1016/j.arr.2020.10102432006687
     [Google Scholar]
  6. BlandA.R. PayneF.M. AshtonJ.C. JamialahmadiT. SahebkarA. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.Pharmacol. Res.202217510598610.1016/j.phrs.2021.10598634800627
     [Google Scholar]
  7. KoushkiK. ShahbazS.K. MashayekhiK. SadeghiM. ZayeriZ.D. TabaM.Y. BanachM. Al-RasadiK. JohnstonT.P. SahebkarA. Anti-inflammatory action of statins in cardiovascular disease: The role of inflammasome and toll-like receptor pathways.Clin. Rev. Allergy Immunol.202160217519910.1007/s12016‑020‑08791‑932378144
     [Google Scholar]
  8. Ferretti G.; Bacchetti T.; Sahebkar A.; Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Prog. Lipid. Res.. 2015, 60, 50-73.10.1016/j.plipres.2015.08.00326416579
  9. SohrevardiS. NasabF. MirjaliliM. BagherniyaM. TaftiA. JarrahzadehM. AzarpazhoohM. SaeidmaneshM. BanachM. JamialahmadiT. SahebkarA. Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial.Arch. Med. Sci.20191751423142810.5114/aoms.2019.8933034522273
     [Google Scholar]
  10. Vahedian-AzimiA MohammadiSM BanachM BeniFH GuestPC Al-RasadiK Improved COVID-19 outcomes following statin therapy: An updated systematic review and meta-analysis.Biomed. Res. Int.202120211901772
     [Google Scholar]
  11. MahalwarR. KhannaD. Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders.Eur. J. Pharmacol.20137111-3576210.1016/j.ejphar.2013.04.02523648561
     [Google Scholar]
  12. BahramiA. ParsamaneshN. AtkinS.L. BanachM. SahebkarA. Effect of statins on toll-like receptors: A new insight to pleiotropic effects.Pharmacol. Res.201813523023810.1016/j.phrs.2018.08.01430120976
     [Google Scholar]
  13. Vahedian-Azimi A.; Mannarino M.R.; Shojaie S.; Rahimibashar F.; Galeh H.E.G.; Banach M.; Bianconi V.; Pirro M.; Sahebkar A.; The effect of statins on the prevalence and mortality of influenza virus infection: A systematic review and meta-analysis. Arch. Med. Sci. 2022, 18(6), 1513-1524.10.5114/aoms/14963336457966
  14. ParizadehS.M.R. AzarpazhoohM.R. MoohebatiM. NematyM. Ghayour-MobarhanM. TavallaieS. RahseparA.A. AminiM. SahebkarA. MohammadiM. FernsG.A.A. Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial.Lipids201146433334010.1007/s11745‑010‑3517‑x21207250
     [Google Scholar]
  15. SahebkarA. ChewG.T. WattsG.F. Recent advances in pharmacotherapy for hypertriglyceridemia.Prog. Lipid Res.2014561476610.1016/j.plipres.2014.07.00225083925
     [Google Scholar]
  16. SahebkarA. KotaniK. SerbanC. UrsoniuS. MikhailidisD.P. JonesS.R. RayK.K. BlahaM.J. RyszJ. TothP.P. MuntnerP. LipG.Y.H. BanachM. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials.Atherosclerosis2015241243344210.1016/j.atherosclerosis.2015.05.02226074317
     [Google Scholar]
  17. SahebkarA. SerbanC. MikhailidisD.P. UndasA. LipG.Y.H. MuntnerP. BittnerV. RayK.K. WattsG.F. HovinghG.K. RyszJ. KasteleinJ.J. BanachM. Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.Thromb. Haemost.2015114354655726017749
     [Google Scholar]
  18. SahebkarA. SerbanC. UrsoniuS. MikhailidisD.P. UndasA. LipG.Y.H. BittnerV. RayK.K. WattsG.F. HovinghG.K. RyszJ. KasteleinJ.J.P. BanachM. The impact of statin therapy on plasma levels of von Willebrand factor antigen.Thromb. Haemost.2016115352053210.1160/th15‑08‑062026632869
     [Google Scholar]
  19. SerbanC. SahebkarA. UrsoniuS. MikhailidisD.P. RizzoM. LipG.Y.H. Kees HovinghG. KasteleinJ.J.P. KalinowskiL. RyszJ. BanachM. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations.Sci. Rep.201551990210.1038/srep0990225970700
     [Google Scholar]
  20. Amin F.; Fathi F.; Reiner Ž.; Banach M.; Sahebkar A.; The role of statins in lung cancer. Arch. Med. Sci. 2021 Mar 18; 18(1):141-15210.5114/aoms/12322535154535PMC8826694
  21. MurrowJ.R. SherS. AliS. UphoffI. PatelR. PorkertM. LeN.A. JonesD. QuyyumiA.A. The differential effect of statins on oxidative stress and endothelial function: Atorvastatin versus pravastatin.J. Clin. Lipidol.201261424910.1016/j.jacl.2011.08.00622264573
     [Google Scholar]
  22. HuangJ. LinS.C. NadershahiA. WattsS.W. SarkarR. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.J. Vasc. Surg.200847359960710.1016/j.jvs.2007.11.00618295111
     [Google Scholar]
  23. LiH. HorkeS. FörstermannU. Oxidative stress in vascular disease and its pharmacological prevention.Trends Pharmacol. Sci.201334631331910.1016/j.tips.2013.03.00723608227
     [Google Scholar]
  24. Flores-MateoG. Carrillo-SantisteveP. ElosuaR. GuallarE. MarrugatJ. BleysJ. CovasM.I. Antioxidant enzyme activity and coronary heart disease: Meta-analyses of observational studies.Am. J. Epidemiol.2009170213514710.1093/aje/kwp11219465742
     [Google Scholar]
  25. YilmazM.I. BaykalY. KilicM. SonmezA. BulucuF. AydinA. SayalA. KocarI.H. Effects of statins on oxidative stress.Biol. Trace Elem. Res.200498211912810.1385/BTER:98:2:11915073410
     [Google Scholar]
  26. RuizM. MorenoJ. RuizN. VargasF. AsensioC. OsunaA., Eds. Effect of statin treatment on oxidative stress and renal function in renal transplantation. Transplantation proceedings.ElsevierAmsterdam2006
     [Google Scholar]
  27. SaveV. PatilN. MoulikN. RajadhyakshaG. Effect of atorvastatin on type 2 diabetic dyslipidemia.J. Cardiovasc. Pharmacol. Ther.200611426227010.1177/107424840629552317220473
     [Google Scholar]
  28. SuY. XuY. SunY.M. LiJ. LiuX.M. LiY.B. LiuG.D. BiS. Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus.J. Cardiovasc. Pharmacol.2010551212510.1097/FJC.0b013e3181bfb1df19786892
     [Google Scholar]
  29. KwakH.B. Thalacker-MercerA. AndersonE.J. LinC.T. KaneD.A. LeeN.S. CortrightR.N. BammanM.M. NeuferP.D. Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes.Free Radic. Biol. Med.201252119820710.1016/j.freeradbiomed.2011.10.44922080086
     [Google Scholar]
  30. KodamanP.H. DulebaA.J. Statins in the treatment of polycystic ovary syndrome.Semin. Reprod. Med.20082611273810.1055/s‑2007‑992933
     [Google Scholar]
  31. KanugulaA.K. GollavilliP.N. VasamsettiS.B. KarnewarS. GopojuR. UmmanniR. KotamrajuS. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: Intermediacy of nitric oxide and antioxidant defence mechanisms.FEBS J.2014281163719373810.1111/febs.1289324964743
     [Google Scholar]
  32. CastroP.F. MirandaR. VerdejoH.E. GreigD. GabrielliL.A. AlcainoH. ChiongM. BustosC. GarciaL. MelladoR. VukasovicJ.L. GodoyI. LavanderoS. Pleiotropic effects of atorvastatin in heart failure: Role in oxidative stress, inflammation, endothelial function, and exercise capacity.J. Heart Lung Transplant.200827443544110.1016/j.healun.2008.01.01218374881
     [Google Scholar]
  33. StolfAM dos Reis LíveroF DreifussAA Bastos-PereiraAL FabosiIA de SouzaCEA Effects of statins on liver cell function and inflammation in septic rats.J Surg Res.2012178288897
     [Google Scholar]
  34. LandmesserU. BahlmannF. MuellerM. SpiekermannS. KirchhoffN. SchulzS. ManesC. FischerD. de GrootK. FliserD. FaulerG. MärzW. DrexlerH. Simvastatin versus ezetimibe: Pleiotropic and lipid-lowering effects on endothelial function in humans.Circulation2005111182356236310.1161/01.CIR.0000164260.82417.3F15867181
     [Google Scholar]
  35. CarrepeiroM.M. RogeroM.M. BertolamiM.C. BotelhoP.B. CastroN. CastroI.A. Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women.Atherosclerosis2011217117117810.1016/j.atherosclerosis.2010.12.01321561620
     [Google Scholar]
  36. ZinelluA. MangoniA.A. A systematic review and meta-analysis of the effect of statins on glutathione peroxidase, superoxide dismutase, and catalase.Antioxidants20211011184110.3390/antiox1011184134829712
     [Google Scholar]
  37. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.Int. J. Surg.20218810590610.1016/j.ijsu.2021.10590633789826
     [Google Scholar]
  38. HigginsJ.P.T. AltmanD.G. GøtzscheP.C. JüniP. MoherD. OxmanA.D. SavovicJ. SchulzK.F. WeeksL. SterneJ.A.C. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.BMJ2011343oct18 2d592810.1136/bmj.d592822008217
     [Google Scholar]
  39. MisraH.P. FridovichI. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.J. Biol. Chem.1972247103170317510.1016/S0021‑9258(19)45228‑94623845
     [Google Scholar]
  40. BroncelM. Koter-MichalakM. Chojnowska-JezierskaJ. The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia.Przegl. Lek.200663973874217479860
     [Google Scholar]
  41. PizziC. ManfriniO. FontanaF. BugiardiniR. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: Role of superoxide dismutase activity.Circulation20041091535810.1161/01.CIR.0000100722.34034.E414699004
     [Google Scholar]
  42. FarrokhiF. MoohebatiM. AghdaeiH.R.A. GhaffarzadeganK. NorouziF. SahebkarA. TavallaieS. AzarpazhoohM.R. Ghayour-MobarhanM. FernsG.A. Effects of statin therapy on serum trace element status in dyslipidemic patients: Results of a randomized placebo- controlled cross-over trial.Clin. Lab.2012589-101005101523163117
     [Google Scholar]
  43. McCordJ.M. FridovichI. Superoxide dismutase.J. Biol. Chem.1969244226049605510.1016/S0021‑9258(18)63504‑55389100
     [Google Scholar]
  44. ChenW.R. LiuH.B. ShaY. ShiY. WangH. YinD.W. ChenY.D. ShiX.M. Effects of statin on arrhythmia and heart rate variability in healthy persons with 48-hour sleep deprivation.J. Am. Heart Assoc.2016511e00383310.1161/JAHA.116.00383327799236
     [Google Scholar]
  45. Carrillo-IbarraS. Miranda-DíazA.G. Sifuentes-FrancoS. Cardona-MuñozE.G. Rodríguez-CarrizalezA.D. Villegas-RiveraG. Román-PintosL.M. Effect of statins on oxidative DNA damage in diabetic polyneuropathy.J. Circ. Biomark.2018710.1177/184945441880409930302131
     [Google Scholar]
  46. JiangF. YangJ. ZhangL. LiR. ZhuoL. SunL. ZhaoQ. Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.Clin. Cardiol.2014379n/a10.1002/clc.2229225156269
     [Google Scholar]
  47. KosenkoE. SuslikovA. VenediktovaN. KaminskyY.G. Erythrocyte antioxidant enzymes in hypertensive patients receiving lisinopril monotherapy or combined lisinopril plus simvastatin therapy. Biochemistry (Moscow).Supplement Series B: Biomedical Chemistry.201044395399
     [Google Scholar]
  48. BeauchampC. FridovichI. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels.Anal. Biochem.197144127628710.1016/0003‑2697(71)90370‑84943714
     [Google Scholar]
  49. ChenM. LiH. WangY. Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals.J. Cardiovasc. Pharmacol.201362332032410.1097/FJC.0b013e31829be05b23714773
     [Google Scholar]
  50. KaminskyY. SuslikovA. KosenkoE. Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes.J. Clin. Pharmacol.201050218018710.1177/009127000934485419841160
     [Google Scholar]
  51. KaminskyY.G. KosenkoE.A. Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo.Free Radic. Res.200842656457310.1080/1071576080215905718569014
     [Google Scholar]
  52. LiangD. ZhangQ. YangH. ZhangR. YanW. GaoH. WangJ. ZhangX. ChenY. CaoF. Anti-oxidative stress effect of loading-dose rosuvastatin prior to percutaneous coronary intervention in patients with acute coronary syndrome: A prospective randomized controlled clinical trial.Clin. Drug Investig.2014341177378110.1007/s40261‑014‑0231‑025186834
     [Google Scholar]
  53. SparksD. SabbaghM. ConnorD. LopezJ. LaunerL. PetanceskaS. BrowneP. WassarD. Johnson- TraverS. LochheadJ. ZiolkowskiC. Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.Curr. Alzheimer Res.20052334335310.2174/156720505436790015974900
     [Google Scholar]
  54. BeutlerE. Red cell metabolism. A manual of biochemical methods.Yale J. Biol. Med.1976493310311
     [Google Scholar]
  55. ShengY. AbreuI.A. CabelliD.E. MaroneyM.J. MillerA.F. TeixeiraM. ValentineJ.S. Superoxide dismutases and superoxide reductases.Chem. Rev.201411473854391810.1021/cr400529624684599
     [Google Scholar]
  56. SolaS. MirM.Q.S. RajagopalanS. HelmyT. TandonN. KhanB.V. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.J. Card. Fail.200511860761210.1016/j.cardfail.2005.05.01116230264
     [Google Scholar]
  57. FukaiT. SiegfriedM.R. Ushio-FukaiM. ChengY. KojdaG. HarrisonD.G. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training.J. Clin. Invest.2000105111631163910.1172/JCI955110841522
     [Google Scholar]
  58. KandeloueiT. AbbasifardM. ImaniD. AslaniS. RaziB. FasihiM. ShafiekhaniS. MohammadiK. JamialahmadiT. ReinerŽ. SahebkarA. Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.Mediators Inflamm.2022202212010.1155/2022/873236035125965
     [Google Scholar]
  59. ReinerŽ. Statins in the primary prevention of cardiovascular disease.Nat. Rev. Cardiol.201310845346410.1038/nrcardio.2013.8023736519
     [Google Scholar]
/content/journals/cmc/10.2174/0929867331666230831145809
Loading
Effect of Statins on Superoxide Dismutase Level: A Systematic Review
Curr. Med. Chem. 32, 1007 (2025); https://doi.org/10.2174/0929867331666230831145809
/content/journals/cmc/10.2174/0929867331666230831145809
/content/journals/cmc/10.2174/0929867331666230831145809
Loading

Data & Media loading...

Supplements

PRISMA checklist and supplementary material are available as supplementary material on the publisher's website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Antioxidant activity; atorvastatin; oxidative stress; simvastatin; SOD; statins; superoxide dismutase

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test